Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study

Abstract Freezing of Gait (FOG) is a common and disabling symptom in patients with Parkinson disease (PD). The relationship between FOG and dopaminergic medication is complex. The aim of the present study was to estimate the prevalence of self-reported FOG, its associated clinical features, and its...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Parkinsonism & related disorders 2015-06, Vol.21 (6), p.644-649
Hauptverfasser: Amboni, M, Stocchi, F, Abbruzzese, G, Morgante, L, Onofrj, M, Ruggieri, S, Tinazzi, M, Zappia, M, Attar, M, Colombo, D, Simoni, L, Ori, A, Barone, P, Antonini, A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 649
container_issue 6
container_start_page 644
container_title Parkinsonism & related disorders
container_volume 21
creator Amboni, M
Stocchi, F
Abbruzzese, G
Morgante, L
Onofrj, M
Ruggieri, S
Tinazzi, M
Zappia, M
Attar, M
Colombo, D
Simoni, L
Ori, A
Barone, P
Antonini, A
description Abstract Freezing of Gait (FOG) is a common and disabling symptom in patients with Parkinson disease (PD). The relationship between FOG and dopaminergic medication is complex. The aim of the present study was to estimate the prevalence of self-reported FOG, its associated clinical features, and its relationship with wearing-off in a wide PD population. This is an observational multicenter study of 634 consecutive non-demented PD patients. Patients were identified either as freezers or non-freezers based on item-3 of the Freezing of Gait-Questionnaire. FOG was then classified as on, off and onoff freezing based on its relationship with wearing-off. Patients were assessed with Unified Parkinson's Disease Rating Scale, Hoehn and Yahr scale, 8-item Parkinson's disease Questionnaire, Mini-Mental State Examination. Data from 593 patients were analyzed, 325 (54.3%) were freezers of whom 200 (61.6%) experienced FOG only during off state (off-freezers), 6 (1.8%) only during on state and 119 (36.6%) either in on and off states or independently of dopaminergic response-related symptoms (onoff-freezers). Overall, freezers vs non-freezers had longer disease duration, more advanced disease and greater disability. Moreover, freezers more frequently reported wearing-off and experienced worse quality of life. Onoff-freezers vs off-freezers were older, more severely disabled, less likely to experience wearing-off, treated with lower levodopa equivalent daily dose and with poorer cognitive performance. Self-reported FOG is mainly recognizable in advanced PD and is associated with more disability and worse quality of life. Onoff-FOG may represent the result of under-treatment or rather interpretable as a distinct clinical entity.
doi_str_mv 10.1016/j.parkreldis.2015.03.028
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1682891814</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1353802015001327</els_id><sourcerecordid>1682891814</sourcerecordid><originalsourceid>FETCH-LOGICAL-c565t-bce25aa3e15731d0d5058f8c5a92dd202e3f25a3c9fd8909b443cf3a7e95b56c3</originalsourceid><addsrcrecordid>eNqNkU1v1DAQQCNERUvhLyAfuSSM7XXicECCdtsiVepKlLPltSfF26yzeJJKy6_H6RaQeuJkS_Pm601RMA4VB15_2FQ7m-4T9j5QJYCrCmQFQr8oTrhuZKm4qF_mv1Sy1CDguHhNtAGARoF8VRwLpdtWLdRJsV0lfLA9RofMRs8s0eCCHdGzDu04JSQ2dIyw78qEuyE9RhLirxDv5sidDSMLka3yQCHSEFmeCS3hR3b7A9n5crliFzeXjMbJ798UR53tCd8-vafF94vl7dlVeX1z-fXs83XpVK3Gcu1QKGslctVI7sErULrTTtlWeC9AoOwyIF3bed1Cu14spOukbbBVa1U7eVq8P9TdpeHnhDSabSCHfW8jDhMZXmuhW675IqP6gLo0ECXszC6FrU17w8HMss3G_JNtZtkGpMmyc-q7py7Teov-b-Ifuxn4cgAw7_oQMBlyYVbtQ0I3Gj-E_-ny6VkR14cYnO3vcY-0GaYUs0vDDQkD5tt89PnmXAFwKRr5G9MiqwE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1682891814</pqid></control><display><type>article</type><title>Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Amboni, M ; Stocchi, F ; Abbruzzese, G ; Morgante, L ; Onofrj, M ; Ruggieri, S ; Tinazzi, M ; Zappia, M ; Attar, M ; Colombo, D ; Simoni, L ; Ori, A ; Barone, P ; Antonini, A</creator><creatorcontrib>Amboni, M ; Stocchi, F ; Abbruzzese, G ; Morgante, L ; Onofrj, M ; Ruggieri, S ; Tinazzi, M ; Zappia, M ; Attar, M ; Colombo, D ; Simoni, L ; Ori, A ; Barone, P ; Antonini, A ; DEEP Study Group</creatorcontrib><description>Abstract Freezing of Gait (FOG) is a common and disabling symptom in patients with Parkinson disease (PD). The relationship between FOG and dopaminergic medication is complex. The aim of the present study was to estimate the prevalence of self-reported FOG, its associated clinical features, and its relationship with wearing-off in a wide PD population. This is an observational multicenter study of 634 consecutive non-demented PD patients. Patients were identified either as freezers or non-freezers based on item-3 of the Freezing of Gait-Questionnaire. FOG was then classified as on, off and onoff freezing based on its relationship with wearing-off. Patients were assessed with Unified Parkinson's Disease Rating Scale, Hoehn and Yahr scale, 8-item Parkinson's disease Questionnaire, Mini-Mental State Examination. Data from 593 patients were analyzed, 325 (54.3%) were freezers of whom 200 (61.6%) experienced FOG only during off state (off-freezers), 6 (1.8%) only during on state and 119 (36.6%) either in on and off states or independently of dopaminergic response-related symptoms (onoff-freezers). Overall, freezers vs non-freezers had longer disease duration, more advanced disease and greater disability. Moreover, freezers more frequently reported wearing-off and experienced worse quality of life. Onoff-freezers vs off-freezers were older, more severely disabled, less likely to experience wearing-off, treated with lower levodopa equivalent daily dose and with poorer cognitive performance. Self-reported FOG is mainly recognizable in advanced PD and is associated with more disability and worse quality of life. Onoff-FOG may represent the result of under-treatment or rather interpretable as a distinct clinical entity.</description><identifier>ISSN: 1353-8020</identifier><identifier>EISSN: 1873-5126</identifier><identifier>DOI: 10.1016/j.parkreldis.2015.03.028</identifier><identifier>PMID: 25899545</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Aged ; Aged, 80 and over ; Antiparkinson Agents - administration &amp; dosage ; Antiparkinson Agents - therapeutic use ; Female ; Freezing of gait ; Freezing Reaction, Cataleptic ; Gait ; Gait Disorders, Neurologic - classification ; Gait Disorders, Neurologic - epidemiology ; Gait Disorders, Neurologic - physiopathology ; Humans ; Levodopa - administration &amp; dosage ; Levodopa - therapeutic use ; Male ; Middle Aged ; Neurology ; Parkinson Disease - drug therapy ; Parkinson Disease - physiopathology ; Parkinson Disease - psychology ; Parkinson's disease ; Prevalence ; Quality of Life - psychology ; Risk Factors ; Self Report ; Severity of Illness Index ; Surveys and Questionnaires ; Wearing-off</subject><ispartof>Parkinsonism &amp; related disorders, 2015-06, Vol.21 (6), p.644-649</ispartof><rights>Elsevier Ltd</rights><rights>2015 Elsevier Ltd</rights><rights>Copyright © 2015 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c565t-bce25aa3e15731d0d5058f8c5a92dd202e3f25a3c9fd8909b443cf3a7e95b56c3</citedby><cites>FETCH-LOGICAL-c565t-bce25aa3e15731d0d5058f8c5a92dd202e3f25a3c9fd8909b443cf3a7e95b56c3</cites><orcidid>0000-0001-9206-6012 ; 0000-0002-0031-5729</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1353802015001327$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25899545$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Amboni, M</creatorcontrib><creatorcontrib>Stocchi, F</creatorcontrib><creatorcontrib>Abbruzzese, G</creatorcontrib><creatorcontrib>Morgante, L</creatorcontrib><creatorcontrib>Onofrj, M</creatorcontrib><creatorcontrib>Ruggieri, S</creatorcontrib><creatorcontrib>Tinazzi, M</creatorcontrib><creatorcontrib>Zappia, M</creatorcontrib><creatorcontrib>Attar, M</creatorcontrib><creatorcontrib>Colombo, D</creatorcontrib><creatorcontrib>Simoni, L</creatorcontrib><creatorcontrib>Ori, A</creatorcontrib><creatorcontrib>Barone, P</creatorcontrib><creatorcontrib>Antonini, A</creatorcontrib><creatorcontrib>DEEP Study Group</creatorcontrib><title>Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study</title><title>Parkinsonism &amp; related disorders</title><addtitle>Parkinsonism Relat Disord</addtitle><description>Abstract Freezing of Gait (FOG) is a common and disabling symptom in patients with Parkinson disease (PD). The relationship between FOG and dopaminergic medication is complex. The aim of the present study was to estimate the prevalence of self-reported FOG, its associated clinical features, and its relationship with wearing-off in a wide PD population. This is an observational multicenter study of 634 consecutive non-demented PD patients. Patients were identified either as freezers or non-freezers based on item-3 of the Freezing of Gait-Questionnaire. FOG was then classified as on, off and onoff freezing based on its relationship with wearing-off. Patients were assessed with Unified Parkinson's Disease Rating Scale, Hoehn and Yahr scale, 8-item Parkinson's disease Questionnaire, Mini-Mental State Examination. Data from 593 patients were analyzed, 325 (54.3%) were freezers of whom 200 (61.6%) experienced FOG only during off state (off-freezers), 6 (1.8%) only during on state and 119 (36.6%) either in on and off states or independently of dopaminergic response-related symptoms (onoff-freezers). Overall, freezers vs non-freezers had longer disease duration, more advanced disease and greater disability. Moreover, freezers more frequently reported wearing-off and experienced worse quality of life. Onoff-freezers vs off-freezers were older, more severely disabled, less likely to experience wearing-off, treated with lower levodopa equivalent daily dose and with poorer cognitive performance. Self-reported FOG is mainly recognizable in advanced PD and is associated with more disability and worse quality of life. Onoff-FOG may represent the result of under-treatment or rather interpretable as a distinct clinical entity.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antiparkinson Agents - administration &amp; dosage</subject><subject>Antiparkinson Agents - therapeutic use</subject><subject>Female</subject><subject>Freezing of gait</subject><subject>Freezing Reaction, Cataleptic</subject><subject>Gait</subject><subject>Gait Disorders, Neurologic - classification</subject><subject>Gait Disorders, Neurologic - epidemiology</subject><subject>Gait Disorders, Neurologic - physiopathology</subject><subject>Humans</subject><subject>Levodopa - administration &amp; dosage</subject><subject>Levodopa - therapeutic use</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neurology</subject><subject>Parkinson Disease - drug therapy</subject><subject>Parkinson Disease - physiopathology</subject><subject>Parkinson Disease - psychology</subject><subject>Parkinson's disease</subject><subject>Prevalence</subject><subject>Quality of Life - psychology</subject><subject>Risk Factors</subject><subject>Self Report</subject><subject>Severity of Illness Index</subject><subject>Surveys and Questionnaires</subject><subject>Wearing-off</subject><issn>1353-8020</issn><issn>1873-5126</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU1v1DAQQCNERUvhLyAfuSSM7XXicECCdtsiVepKlLPltSfF26yzeJJKy6_H6RaQeuJkS_Pm601RMA4VB15_2FQ7m-4T9j5QJYCrCmQFQr8oTrhuZKm4qF_mv1Sy1CDguHhNtAGARoF8VRwLpdtWLdRJsV0lfLA9RofMRs8s0eCCHdGzDu04JSQ2dIyw78qEuyE9RhLirxDv5sidDSMLka3yQCHSEFmeCS3hR3b7A9n5crliFzeXjMbJ798UR53tCd8-vafF94vl7dlVeX1z-fXs83XpVK3Gcu1QKGslctVI7sErULrTTtlWeC9AoOwyIF3bed1Cu14spOukbbBVa1U7eVq8P9TdpeHnhDSabSCHfW8jDhMZXmuhW675IqP6gLo0ECXszC6FrU17w8HMss3G_JNtZtkGpMmyc-q7py7Teov-b-Ifuxn4cgAw7_oQMBlyYVbtQ0I3Gj-E_-ny6VkR14cYnO3vcY-0GaYUs0vDDQkD5tt89PnmXAFwKRr5G9MiqwE</recordid><startdate>20150601</startdate><enddate>20150601</enddate><creator>Amboni, M</creator><creator>Stocchi, F</creator><creator>Abbruzzese, G</creator><creator>Morgante, L</creator><creator>Onofrj, M</creator><creator>Ruggieri, S</creator><creator>Tinazzi, M</creator><creator>Zappia, M</creator><creator>Attar, M</creator><creator>Colombo, D</creator><creator>Simoni, L</creator><creator>Ori, A</creator><creator>Barone, P</creator><creator>Antonini, A</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9206-6012</orcidid><orcidid>https://orcid.org/0000-0002-0031-5729</orcidid></search><sort><creationdate>20150601</creationdate><title>Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study</title><author>Amboni, M ; Stocchi, F ; Abbruzzese, G ; Morgante, L ; Onofrj, M ; Ruggieri, S ; Tinazzi, M ; Zappia, M ; Attar, M ; Colombo, D ; Simoni, L ; Ori, A ; Barone, P ; Antonini, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c565t-bce25aa3e15731d0d5058f8c5a92dd202e3f25a3c9fd8909b443cf3a7e95b56c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antiparkinson Agents - administration &amp; dosage</topic><topic>Antiparkinson Agents - therapeutic use</topic><topic>Female</topic><topic>Freezing of gait</topic><topic>Freezing Reaction, Cataleptic</topic><topic>Gait</topic><topic>Gait Disorders, Neurologic - classification</topic><topic>Gait Disorders, Neurologic - epidemiology</topic><topic>Gait Disorders, Neurologic - physiopathology</topic><topic>Humans</topic><topic>Levodopa - administration &amp; dosage</topic><topic>Levodopa - therapeutic use</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neurology</topic><topic>Parkinson Disease - drug therapy</topic><topic>Parkinson Disease - physiopathology</topic><topic>Parkinson Disease - psychology</topic><topic>Parkinson's disease</topic><topic>Prevalence</topic><topic>Quality of Life - psychology</topic><topic>Risk Factors</topic><topic>Self Report</topic><topic>Severity of Illness Index</topic><topic>Surveys and Questionnaires</topic><topic>Wearing-off</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Amboni, M</creatorcontrib><creatorcontrib>Stocchi, F</creatorcontrib><creatorcontrib>Abbruzzese, G</creatorcontrib><creatorcontrib>Morgante, L</creatorcontrib><creatorcontrib>Onofrj, M</creatorcontrib><creatorcontrib>Ruggieri, S</creatorcontrib><creatorcontrib>Tinazzi, M</creatorcontrib><creatorcontrib>Zappia, M</creatorcontrib><creatorcontrib>Attar, M</creatorcontrib><creatorcontrib>Colombo, D</creatorcontrib><creatorcontrib>Simoni, L</creatorcontrib><creatorcontrib>Ori, A</creatorcontrib><creatorcontrib>Barone, P</creatorcontrib><creatorcontrib>Antonini, A</creatorcontrib><creatorcontrib>DEEP Study Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Parkinsonism &amp; related disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Amboni, M</au><au>Stocchi, F</au><au>Abbruzzese, G</au><au>Morgante, L</au><au>Onofrj, M</au><au>Ruggieri, S</au><au>Tinazzi, M</au><au>Zappia, M</au><au>Attar, M</au><au>Colombo, D</au><au>Simoni, L</au><au>Ori, A</au><au>Barone, P</au><au>Antonini, A</au><aucorp>DEEP Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study</atitle><jtitle>Parkinsonism &amp; related disorders</jtitle><addtitle>Parkinsonism Relat Disord</addtitle><date>2015-06-01</date><risdate>2015</risdate><volume>21</volume><issue>6</issue><spage>644</spage><epage>649</epage><pages>644-649</pages><issn>1353-8020</issn><eissn>1873-5126</eissn><abstract>Abstract Freezing of Gait (FOG) is a common and disabling symptom in patients with Parkinson disease (PD). The relationship between FOG and dopaminergic medication is complex. The aim of the present study was to estimate the prevalence of self-reported FOG, its associated clinical features, and its relationship with wearing-off in a wide PD population. This is an observational multicenter study of 634 consecutive non-demented PD patients. Patients were identified either as freezers or non-freezers based on item-3 of the Freezing of Gait-Questionnaire. FOG was then classified as on, off and onoff freezing based on its relationship with wearing-off. Patients were assessed with Unified Parkinson's Disease Rating Scale, Hoehn and Yahr scale, 8-item Parkinson's disease Questionnaire, Mini-Mental State Examination. Data from 593 patients were analyzed, 325 (54.3%) were freezers of whom 200 (61.6%) experienced FOG only during off state (off-freezers), 6 (1.8%) only during on state and 119 (36.6%) either in on and off states or independently of dopaminergic response-related symptoms (onoff-freezers). Overall, freezers vs non-freezers had longer disease duration, more advanced disease and greater disability. Moreover, freezers more frequently reported wearing-off and experienced worse quality of life. Onoff-freezers vs off-freezers were older, more severely disabled, less likely to experience wearing-off, treated with lower levodopa equivalent daily dose and with poorer cognitive performance. Self-reported FOG is mainly recognizable in advanced PD and is associated with more disability and worse quality of life. Onoff-FOG may represent the result of under-treatment or rather interpretable as a distinct clinical entity.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>25899545</pmid><doi>10.1016/j.parkreldis.2015.03.028</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0001-9206-6012</orcidid><orcidid>https://orcid.org/0000-0002-0031-5729</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1353-8020
ispartof Parkinsonism & related disorders, 2015-06, Vol.21 (6), p.644-649
issn 1353-8020
1873-5126
language eng
recordid cdi_proquest_miscellaneous_1682891814
source MEDLINE; Elsevier ScienceDirect Journals
subjects Aged
Aged, 80 and over
Antiparkinson Agents - administration & dosage
Antiparkinson Agents - therapeutic use
Female
Freezing of gait
Freezing Reaction, Cataleptic
Gait
Gait Disorders, Neurologic - classification
Gait Disorders, Neurologic - epidemiology
Gait Disorders, Neurologic - physiopathology
Humans
Levodopa - administration & dosage
Levodopa - therapeutic use
Male
Middle Aged
Neurology
Parkinson Disease - drug therapy
Parkinson Disease - physiopathology
Parkinson Disease - psychology
Parkinson's disease
Prevalence
Quality of Life - psychology
Risk Factors
Self Report
Severity of Illness Index
Surveys and Questionnaires
Wearing-off
title Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T07%3A55%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20and%20associated%20features%20of%20self-reported%20freezing%20of%20gait%20in%20Parkinson%20disease:%20The%20DEEP%20FOG%20study&rft.jtitle=Parkinsonism%20&%20related%20disorders&rft.au=Amboni,%20M&rft.aucorp=DEEP%20Study%20Group&rft.date=2015-06-01&rft.volume=21&rft.issue=6&rft.spage=644&rft.epage=649&rft.pages=644-649&rft.issn=1353-8020&rft.eissn=1873-5126&rft_id=info:doi/10.1016/j.parkreldis.2015.03.028&rft_dat=%3Cproquest_cross%3E1682891814%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1682891814&rft_id=info:pmid/25899545&rft_els_id=S1353802015001327&rfr_iscdi=true